TrialBMC pulmonary medicine2020

A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD.

Courtney Crim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.